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In response to various infectious and sterile stimuli neutrophils release chromatin
decorated with bactericidal proteins, referred to as NETs. Their scaffolds are formed
from chromatin fibers which display an apparent diameter of 15–17 nm and mainly
consist from DNA (2 nm) and DNA-associated histones (11 nm). The NET-forming strands
are thus not naked DNA but higher ordered chromatin structures. The histones may
be released from the NET, especially if their tail arginines have been citrullinated.
Several studies indicate that extracellular histones are toxic for mammalian epithelia and
endothelia and contribute to the microvascular dysfunction observed e.g., in patients
suffering from autoimmune diseases or sepsis. NETs formed at sites of very high
neutrophil densities tend to clump and form fairly stable enzymatically active aggregates,
referred to as aggNETs. The latter are endowed with a bunch of enzymes that cleave,
bind, and/or modify autologous as well as foreign macromolecules. The tight binding of
the serine proteases to the matrix precludes the spread of these toxic enzymes into the
tissue but still allows the access of soluble inflammatorymediators to the enzymatic active
internal surfaces of the NETs where they are degraded. Here, we describe that externally
added histones are removed from culture supernatants of aggNETs. We will address
the fate of the histones and discuss the feature on the background of neutrophil-driven
diseases and the resolution of inflammation.
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INTRODUCTION
Histones are a major part of nucleosomes, the basic structural unit of chromatin in the nuclei of
eukaryotic cells (1). These nucleosomes each consist of two copies of the histones H2A, H2B, H3,
and H4 forming an octamer with 140–150 base pairs of superhelical DNA wrapped around the
histone core (2). The linker histone H1 assembles the repeating nucleosome cores into higher-order
structures (3). Biosynthesis of histones takes places in the cytoplasm and many histones transiently
remain there (4, 5); some reportedly accumulate on the plasma membranes (6). Extra-nuclear
localization of histones is also found associated with the DNA structures in neutrophil extracellular
traps (NETs), first described in 2004 as bactericidal mechanism (7). Furthermore, histones display
anti-microbial activity reviewed in Hoeksema et al. (8), and have been implicated in tissue
destruction, sepsis (9), and thrombosis (10). Mechanistically, histones reportedly display direct
cytotoxic effect on eukaryotic cells (11), may directly activate phagocytes (12) and platelets (13).
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Since their first description in 2004, NETs are now known to
play a role in physiology and pathology (14). In high densities
these NETs tend to aggregate; these aggNETs, first described to
be induced by monosodium urate crystals (MSU) orchestrate
the resolution of inflammation in gout by the degradation of
inflammatory cytokines (15). With increasing cell densities the
proteolytic degradation of cytokines/chemokines outweighs their
release (16). The granular neutrophil elastase, a major protein of
NETs and aggNETs, degrades various proteins of the extracellular
matrix or immunoglobulins (17). Here, we describe that histones
are sequestered and detoxified by aggNETs and that this increased
viability of epithelial cells in contact to extracellular histones.
MATERIALS AND METHODS
Preparation of AggNETs
We isolated polymorphonuclear cells (PMN) from healthy
donors (permit #193/13B from the local ethical committee;
written informed consent of participants) by Ficoll density
gradient (Lymphoflot, Bio-Rad Laboratories, Inc.) as described
previously (18). The granulocytes were then incubated with 50
pg/cell monosodium urate crystals (MSU) for 18 h at 37◦C.
Successful formation of aggNETs is visible without magnification
as depicted in Figure S1E in bright-field as well as under UV
(∼312 nm excitation) after staining with 1 mg/ml propidium
iodide (Sigma-Aldrich) for 2 h. Macrophotographs were taken
using a Nikon D700.
Biotinylation of Histones
We biotinylated calf thymus histones (Sigma-Aldrich) using
the EZ-LinkTM Sulfo-NHS-LC-Biotinylation Kit (Thermo Fisher
Scientific) according to manufacturer’s instructions.
Treatment of Histones With
AggNETs/Neutrophil Elastase/Proteinase3
We incubated 1 mg/ml of biotinylated histones with or without
(1) aggNETs, (2) 5 mU Neutrophil Elastase (Sigma-Aldrich) or,
(3) 5 mU Proteinase3 (Elastin Products Company) in RPMI 1640
medium (Thermo Fisher Scientific) for 24 h at 37◦C. If indicated
we added the neutrophil elastase inhibitors Sivelestat (6.6µM) or
Elafin (166µM) (both Sigma-Aldrich).
SDS-PAGE and Western Blot Analysis
We added 5x PAGE-buffer (2% SDS, 10% glycerol, 5% β-
mercaptoethanol, 0.01% bromophenol blue in 60mMTris-Cl pH
6.8) to the samples and denatured them at 95◦C for 10min.
SDS-PAGE was performed using SERVAGelTM TG PRiMETM
4–20% gels (SERVA Electrophoresis GmbH) for 2.5 h at 100V.
Gels were either transferred onto an Immobilon-PSQ PVDF
membrane (Merck Millipore Ltd.) using a Trans-Blot R© SD
Semi-Dry Transfer Cell (Bio-Rad Laboratories, Inc.) for 1 h
at 350mA or stained with 0.1% Coomassie Brilliant-Blue-
G250 (Sigma-Aldrich). Macrophotographs of the Coomassie gels
were taken using a Nikon D700. Membranes were blocked
with 5% powdered milk (Carl Roth) in Tris-buffered saline
(TBS) for 2 h at RT. We detected histone H1 employing
rabbit anti-human histone H1.0 antibody [EPR6536] (ab134914,
Abcam) overnight at 4◦C followed by goat anti-rabbit IgG HRP
Antibody (4030-05, Southern Biotech) for 1 h at RT. Biotinylation
was detected with PierceTM High Sensitivity Streptavidin-HRP
(21130, Thermo Fisher Scientific). We developed Blots using
Celvin R© S-320+ (Biostep).
Prediction and Visualization of Neutrophil
Elastase Cleaving Sites
We used the sequence of bovine histone H1.3 (A7MAZ5,
UniProtKB) to model its structure with SWISS-MODEL (19).
Neutrophil Elastase cleavage sites on histone H1.3 were predicted
using the ExPASy PeptideCutter tool (20) and were visualized
using the RasMol Molecular Graphics Visualization Tool
V2.7.5 (21).
In vitro Histone Cytotoxicity Assay
Analyses by flow cytometry of HeLa cells treated with soluble
histones or aggNET pre-treated histones was performed using
the four color staining method adapted from Janko et al.
(22) and Munoz et al. (23). Briefly, 24 h after seeding of
HeLa cells into CELLSTAR R© 24-well plates (Greiner Bio-One
GmbH), the cells were treated for 1 h with 500 µg of histones,
histones pre-incubated with aggNETs or aggNET supernatant
in serum-free medium. Mock-treated cells served as controls.
After removal of the media to fresh tubes, we washed the cells
with DPBS (Thermo Fisher Scientific), detached them using
Trypsin/EDTA (Merck) and combined them with the original
media. After centrifugation, cells were resuspended in Ringer’s
solution (Fresenius Kabi) containing 1µg/ml AnnexinA5,
1µg/ml propidium iodide, 1µg/ml Hoechst33342, and
10 nM 1,1
′
-dimethyl-3,3,3
′
,3
′
-tetramethylindodicarbocyanine
iodide. Flow cytometry was performed using a Gallios Flow
Cytometer (Beckman-Coulter) and Kaluza Analysis Software
V2.1 (Beckman-Coulter). Graphs were created using Prism R©
V5.03 (GraphPad Software). Pictures of cells were taken using
a Canon Eos 6D, the Eos Utility3 software (both Canon) in
combination with an Axiovert 25 inverted microscope (Carl
Zeiss) and the Adobe Photoshop CS5 V12.0.1 (Adobe Systems).
RESULTS
AggNETs Proteolytically Degrade Histones
Incubation of calf thymus histones with aggNETs for 24 h
results in a complete degradation of histone H1 (Figure 1A)
as shown by Coomassie staining of protein. Histone H1 was
only detected by Western Blot analysis in the untreated sample,
but neither in the aggNET-treated sample nor in the aggNET
itself. We biotinylated the histone samples to exclude that the
epitope recognized by the antibody was cleaved and therefore
not recognized by Western Blotting. The biotinylation was
again only detected in the untreated sample but neither in
the aggNET-treated ones nor in the aggNETs. Proteinase3
(PR3) and Neutrophil Elastase (NE) are hallmark proteases
located in the azurophilic granula of viable neutrophils and
on the surfaces of aggNETs. As shown in Figures 1B,C, PR3
and NE degrade histone H1; the reaction is prevented by the
specific inhibitors Elafin and Sivelestat, respectively. Prediction
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FIGURE 1 | aggNETs degrade histones. (A) Histones incubated with aggNETs are degraded as seen in Coomassie and staining and anti-histone H1 Blot. The
biotinylationed histones are not bound by the aggNETs. (B) Proteinase3 (PR3) degrades histones. This degradation is inhibited by Elafin as seen in the Coomassie
staining. (C) Neutrophil Elastase (NE) degrades histones, specifically inhibited by Sivelestat as shown in the Coomassie staining. (D) SWISS-MODEL of histone H1
(amino acids 39–119) with the cleavage sites for NE as predicted by ExPASy PeptideCutter. (E) NE and aggNETs favor histone over bovine serum albumin (BSA) and
human Immunoglobulin G (IgG) for degradation; whereas PR3 can only degrade histones. Degradation of biotinylated histones by aggNETs is not inhibited by
Sivelestat or Elafin or a combination of both as seen by the detection of Streptavidin HRP in Western Blot analysis. SDS-PAGE, Western Blot Analysis and Coomassie
staining in (A–C) were performed after incubation of the samples for 24 h at 37◦C. For (E) the incubation time was 8 h at 37◦C. All images shown are representative
images of at least three independent experiments. The full-sized images are shown in Figures S1A–D. The successful formation of an aggNET is shown in the
macrophotographs in Figure S1E in bright-field and under UV after staining with propidium iodide.
by ExPASy PeptideCutter shows that bovine histone H1.3 (amino
acids 39–119) exhibits various cleavage sites for NE (Figure 1D).
Importantly, this degradation favors histone over bovine serum
albumin (BSA) or human immunoglobulin G (IgG) (Figure 1E).
Only NE and aggNETs but not PR3 slightly decrease the amount
of full-size BSA and IgG. For NE, this was prevented by its
specific inhibitor Sivelestat. Surprisingly, neither the addition of
Sivelestat nor of Elafin nor a combination of both blocked the
degradation of histones by aggNETs at any given time point
and concentration.
AggNET-Treatment of Histones Attenuates
Cellular Cytotoxicity
As soon as 1 h after treatment with 500µg/ml histone mix HeLa
cells are in a bad shape, increase clustering and apparently die
as displayed in the bright-field microscopic images (Figure 2A).
Pre-treatment of histones with aggNETs prevented this fate.
The supernatants of aggNET (aggNET-SN) did not affect the
viability of the cells. Flow cytometry revealed that culture
in the presence of histones markedly reduced viability and
increased apoptosis and necrosis in HeLa cells (Figure 2B). This
histone-mediated cytotoxicity is attenuated by pre-treatment
with aggNETs. Detailed analyses of the different forms of cell
death is depicted in Figure 2C and showed that the pre-
treatment with aggNETs significantly decreased early apoptotic,
apoptotic and primary necrotic cells; the population of secondary
necrotic HeLa cells was only slightly increased. HeLa cells
co-cultured with aggNET-SN show comparable viability as
medium controls. Therefore, we can exclude that the incomplete
rescue in aggNET pre-treated histones is caused by toxic
aggNET- derived mediators.
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FIGURE 2 | Pre-treatment of histones with aggNETs attenuates histone-mediated cellular cytotoxicity. (A) Light microscope images in 10x magnification of HeLa cells
before and after treatment with (1) 500 µg histones, (2) histones pre-treated with aggNETs for 24 h or (3) aggNET supernatant (SN). (B) Overview of different forms of
cell death of HeLa cells after treatment assessed by flow cytometry. Pre-treatment of histones with aggNETs increases viability of HeLa cells. (C) Detailed analysis of
the different forms of cell death. Viability of HeLa cells incubated with aggNET-treated histones is significantly increased compared to histone treatment due to a
reduction in early apoptosis, apoptosis and primary (1◦) necrosis. Standard error of mean was calculated from three independent experiments. ***p ≤ 0.001,
**p ≤ 0.01, and *p ≤ 0.05 as determined by Two-way ANOVA with Bonferroni post testing. The gating strategy for flow cytometer analysis is depicted in Figure S2.
DISCUSSION
Here, we show for the first time that aggNETs sequester and
degrade histones, and thus attenuate their cytotoxic effect on
epithelial cells. This process was executed by at least two
aggNET-borne serine proteases, NE and PR3. We already have
demonstrated the ability of aggNETs to resolve inflammation
by the proteolytical degradation of inflammatory cytokines and
chemokines (15, 16). NE is established to degrade various
proteins, such as immunoglobulins and extracellular matrix
components (17, 24). The degradation of histones by NE and PR3
was inhibited by Sivelestat or Elafin, respectively. Importantly,
the degradation of histones by aggNETs was resistant to the
two inhibitors. Interestingly, a decreased inhibitory capacity
of the natural proteinous inhibitors α-1 anti-trypsin and
ß2-macroglobulin for membrane-associated NE was already
reported before the first description of NET formation (25).
The cytotoxic effect of histones on epithelial cells described
here, confirms already existing literature (9, 12). This is especially
true when the histone release is exaggerated and not properly
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controlled. Here, we analyze this cytotoxic effect in more detail
using a four color staining method to discriminate between
different states of apoptosis and necrosis as described previously
(22, 23). The addition of histones to HeLa cells induced profound
apoptosis and necrosis (>90% of the cells). This can be partially
rescued pre-treating the histones with aggNETs. This procedure
increased viability to 50%. To examine if toxic proteins/peptides
are released from the aggNETs, we also co-cultured the cells with
aggNET-SN only; the cell viability did not differ from medium
controls. It is conceivable that some of the small histone-derived
peptides, too small to be detected in PAGE, retain residual
cytotoxic activities.
Extracellular histones are described as major mediators of
death in sepsis due to their contribution to endothelial injury
and dysfunction, hemorrhage, thrombosis and organ failure (9).
Released histones potentially act as damage-associated molecular
pattern molecules (DAMPs) (26) and signal through toll-like
receptors (TLR) 2 and 4 leading to a massive pro-inflammatory
cytokine production (27). Moreover, histones are shown to
enhance plasma thrombin generation and the blood clotting
process by involvement of the platelet TLR2 and TLR4 (13).
Histones are further released during trauma or severe cellular
stress mediating their cytotoxicity by triggering an increased
calcium flux in immune and endothelial cells (12).
Histones, released during NET formation, were described in
the circulation of patients suffering from autoimmune diseases
such as systemic lupus erythematosus (28) or rheumatoid
arthritis (29) and were discussed to cause NET-associated
tissue destruction. Histones not only act as autoantigens but
also prevented the degradation of DNA by the formation of
DNA-histone complexes (28). Here we describe that aggNETs
degrade and detoxify histones and thus contribute to the
resolution of histone-induced inflammatory reactions. If this
also takes place in vivo and how it can be further enhanced
to completely rescue cells from histone-mediated cytotoxicity,
needs further investigation. We conclude that histones are
targeted by aggNETs for degradation. This leads to a decreased
cytotoxicity of histones and, therefore, fosters the resolution
of inflammation.
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